Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Neuroone Medical Technologies (NMTC) Gross Margin (2020 - 2025)

Historic Gross Margin for Neuroone Medical Technologies (NMTC) over the last 10 years, with Q4 2025 value amounting to 54.2%.

  • Neuroone Medical Technologies' Gross Margin fell 46500.0% to 54.2% in Q4 2025 from the same period last year, while for Dec 2025 it was 54.87%, marking a year-over-year increase of 72100.0%. This contributed to the annual value of 56.51% for FY2025, which is 252500.0% up from last year.
  • Neuroone Medical Technologies' Gross Margin amounted to 54.2% in Q4 2025, which was down 46500.0% from 55.77% recorded in Q3 2025.
  • Over the past 5 years, Neuroone Medical Technologies' Gross Margin peaked at 58.85% during Q4 2024, and registered a low of 115.81% during Q1 2021.
  • In the last 5 years, Neuroone Medical Technologies' Gross Margin had a median value of 26.67% in 2023 and averaged 4.76%.
  • Its Gross Margin has fluctuated over the past 5 years, first soared by 1057700bps in 2023, then crashed by -46500bps in 2025.
  • Neuroone Medical Technologies' Gross Margin (Quarter) stood at 38.81% in 2021, then soared by 72bps to 10.74% in 2022, then soared by 354bps to 27.24% in 2023, then skyrocketed by 116bps to 58.85% in 2024, then dropped by -8bps to 54.2% in 2025.
  • Its Gross Margin stands at 54.2% for Q4 2025, versus 55.77% for Q3 2025 and 53.94% for Q2 2025.